Literature DB >> 27846034

An update on classification and management of urosepsis.

Florian M E Wagenlehner1, Zafer Tandogdu, Truls E Bjerklund Johansen.   

Abstract

PURPOSE OF REVIEW: The urinary tract is the infection site in severe sepsis/septic shock in 10-30%. RECENT
FINDINGS: There is a new Sepsis definition focusing on severe sepsis. Urosepsis is mainly due to obstructed uropathy of the upper urinary tract. The pathogenesis of sepsis is complex and is driven by the innate immune system. In the further course immunosuppression is developing.Management of urosepsis includes early diagnosis, early initiation of treatment such as identification and control of the complicating factor in the urinary tract and the specific sepsis therapy. As part of early diagnosis the value of the new defining criteria is still to be known. The management bundles are regularly updated according to the surviving sepsis campaign guidelines.
SUMMARY: Sepsis has still a high morbidity and mortality rate. Although definition and diagnosis of sepsis has been recently updated, its translation into urosepsis management requires validation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27846034     DOI: 10.1097/MOU.0000000000000364

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  14 in total

1.  The prognostic performance of Sepsis-3 and SIRS criteria for patients with urolithiasis-associated sepsis transferred to ICU following surgical interventions.

Authors:  Bowen Shi; Fei Shi; Ke Xu; Liuhui Shi; Haixiao Tang; Ning Wang; Yanyuan Wu; Jun Gu; Jie Ding; Yunteng Huang
Journal:  Exp Ther Med       Date:  2019-09-26       Impact factor: 2.447

2.  Conservative management of staghorn stones.

Authors:  M Alsawi; T Amer; M Mariappan; S Nalagatla; A Ramsay; O Aboumarzouk
Journal:  Ann R Coll Surg Engl       Date:  2020-01-10       Impact factor: 1.891

Review 3.  Immunomodulation therapy offers new molecular strategies to treat UTI.

Authors:  Daniel Butler; Ines Ambite; Murphy Lam Yim Wan; Thi Hien Tran; Björn Wullt; Catharina Svanborg
Journal:  Nat Rev Urol       Date:  2022-06-22       Impact factor: 16.430

4.  Assembly dynamics of FtsZ and DamX during infection-related filamentation and division in uropathogenic E. coli.

Authors:  Bill Söderström; Matthew J Pittorino; Daniel O Daley; Iain G Duggin
Journal:  Nat Commun       Date:  2022-06-25       Impact factor: 17.694

Review 5.  [Complicated urinary tract infections].

Authors:  J Kranz; F M E Wagenlehner; L Schneidewind
Journal:  Urologe A       Date:  2020-12       Impact factor: 0.639

Review 6.  Computed tomography imaging of septic shock. Beyond the cause: the "CT hypoperfusion complex". A pictorial essay.

Authors:  Marco Di Serafino; Daniela Viscardi; Francesca Iacobellis; Luigi Giugliano; Luigi Barbuto; Gaspare Oliva; Roberto Ronza; Antonio Borzelli; Antonio Raucci; Filomena Pezzullo; Maria Giovanna De Cristofaro; Luigia Romano
Journal:  Insights Imaging       Date:  2021-06-05

7.  A Novel Method of Serum Resistance by Escherichia coli That Causes Urosepsis.

Authors:  Carrie F Coggon; Andrew Jiang; Kelvin G K Goh; Ian R Henderson; Mark A Schembri; Timothy J Wells
Journal:  mBio       Date:  2018-06-26       Impact factor: 7.867

Review 8.  Epidemiology, definition and treatment of complicated urinary tract infections.

Authors:  Florian M E Wagenlehner; Truls E Bjerklund Johansen; Tommaso Cai; Bela Koves; Jennifer Kranz; Adrian Pilatz; Zafer Tandogdu
Journal:  Nat Rev Urol       Date:  2020-08-25       Impact factor: 14.432

9.  Risk factors for urosepsis in chronic kidney disease patients with urinary tract infections.

Authors:  Zorica Dimitrijevic; Goran Paunovic; Danijela Tasic; Branka Mitic; Dragoslav Basic
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

10.  Development and validation of a risk-prediction nomogram for patients with ureteral calculi associated with urosepsis: A retrospective analysis.

Authors:  Ming Hu; Xintai Zhong; Xuejiang Cui; Xun Xu; Zhanying Zhang; Lixian Guan; Quanyao Feng; Yiheng Huang; Weilie Hu
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.